The patient has diabetes, hyperlipidemia, a cardiac stent, and bilateral lower extremity arterial occlusive disease, and requires a prescription for chronic disease medications.

Poor blood sugar control in diabetes can easily lead to various complications, affecting blood vessels and nerve function throughout the body. Hyperlipidemia further accelerates the progression of atherosclerosis and is an important risk factor for cardiovascular and lower extremity vascular diseases. Continuous antiplatelet therapy is required after cardiac stent implantation to prevent thrombosis. Lower extremity peripheral artery occlusive disease results from vascular stenosis or occlusion, leading to insufficient blood supply to the lower limbs.

Diabetes: Adjust hypoglycemic medications according to blood glucose monitoring results, such as increasing insulin dosage or switching types of antidiabetic drugs. At the same time, strictly control diet, follow the principle of low sugar and high fiber intake, and engage in appropriate physical activity.

Hyperlipidemia: Based on existing statin therapy, consider combination therapy with drugs such as ezetimibe according to lipid profile re-examination results to enhance lipid control.

Post cardiac stent implantation: Continue to take antiplatelet medications such as aspirin and clopidogrel regularly. Periodically recheck cardiac function indicators and coagulation profiles, and seek timely medical attention if any discomfort occurs.

Lower extremity peripheral artery occlusive disease: Circulation-improving medications such as alprostadil may be used, and vascular interventional treatment or surgical therapy may be considered when necessary. Additionally, patients should keep their lower limbs warm, avoid injuries, and elevate their lower limbs appropriately while resting to promote blood return.